1-6 of 6
JM Rowe
Close
Sort by
Journal Articles

A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

JM Rowe, JW Andersen, JJ Mazza, JM Bennett, E Paietta, FA Hayes, D Oette, PA Cassileth, EA Stadtmauer, PH Wiernik
Journal: Blood
Blood (1995) 86 (2): 457–462.
https://doi.org/10.1182/blood.V86.2.457.bloodjournal862457
Published: 1995
Journal Articles

Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia

JM Rowe, AY Chang, JM Bennett
Journal: Blood
Blood (1988) 71 (4): 992–996.
https://doi.org/10.1182/blood.V71.4.992.992
Published: 1988
Journal Articles

Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases

JL Liesveld, JM Rowe, MA Lichtman
Journal: Blood
Blood (1987) 69 (3): 820–826.
https://doi.org/10.1182/blood.V69.3.820.820
Published: 1987
Journal Articles

Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia

JM Rowe, MA Lichtman
Journal: Blood
Blood (1984) 63 (5): 1230–1234.
https://doi.org/10.1182/blood.V63.5.1230.1230
Published: 1984
Journal Articles

Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations

MA Lichtman, JM Rowe
Journal: Blood
Blood (1982) 60 (2): 279–283.
https://doi.org/10.1182/blood.V60.2.279.279
Published: 1982
Journal Articles

Attachment of particle-bound IgG and complement to human neutrophils

WD Lawrence, CH Packman, JM Rowe, MA Lichtman
Journal: Blood
Blood (1981) 58 (4): 772–781.
https://doi.org/10.1182/blood.V58.4.772.772
Published: 1981